The Effect of Structured Lifestyle Modification and Yoga Practice on Metabolic Processes Associated With Cardiovascular Disease
Age: 18 - 80 years
Healthy Subjects: No
Study Phase: N/A
Recruitment Status: Recruiting
Start Date: January 24, 2022
End Date: December 01, 2023
- Subjects eligible for the study are 18-80 year old adults.
- Underwent percutaneous coronary intervention (PCI) at the catheterization lab of Mount Sinai Hospital (New York, New York) or have non-obstructive coronary artery disease and at least one CVD risk factor (hypertension, hypercholesterolemia, diabetes mellitus, or obesity) or metabolic abnormality (fasting plasma glucose ≥ 100 mg/dl, documented previous diagnosis of hypertension, serum triglycerides ≥ 150 mg/dl, or HDL cholesterol < 40 mg/dl).
- Subjects diagnosed with metabolic syndrome, which is defined as three or more of the following conditions: (1) Central or abdominal obesity (waist circumference > 40 inches for men and > 35 inches for women); (2) High triglycerides (≥150 mg/dL or triglycerides treatment); (3) Low HDL cholesterol (<40 mg/dL for men and <50 mg/dL for women) or low HDL-C treatment; (4) High blood pressure (≥130/85 mmHg) or antihypertensive medications; (5) High fasting glucose (≥100 mg/dL) or type 2 diabetes mellitus.
- Participants must be able to willingly consent to study participation and must be able to comply with the study requirements.
- Physical/psychological limitation or unwillingness to practice yoga,
- Congestive heart failure, known arrthymias or prior Automated Implantable Cardioverter-Defibrillator /pacemaker or any metallic implants,
- Rheumatological/immunological diseases,
- History of transplant,
- Moderate to severe chronic obstructive pulmonary disease, debilitating or severe systemic Illness,
- Subjects who are pregnant or postpartum less than 6 months,
- Liver disease or alcohol use of more than 7 alcoholic drinks/week in women and more than 14 drinks/week in men